ArticleTechnology in cancer research & treatment

The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study.

Yuting Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.